American Well Corporation (AMWL)
| Market Cap | 237.61M +169.9% |
| Revenue (ttm) | 218.53M -19.0% |
| Net Income | -78.11M |
| EPS | -4.74 |
| Shares Out | 17.01M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 102,374 |
| Open | 13.21 |
| Previous Close | 13.20 |
| Day's Range | 13.21 - 14.27 |
| 52-Week Range | 3.71 - 14.27 |
| Beta | 1.68 |
| Analysts | Hold |
| Price Target | 12.80 (-8.38%) |
| Est. Earnings | Nov 3, 2026 |
About AMWL
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into th... [Read more]
Financial Performance
In 2025, American Well's revenue was $249.33 million, a decrease of -1.98% compared to the previous year's $254.36 million. Losses were -$95.70 million, -54.02% less than in 2024.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for AMWL stock is "Hold." The 12-month stock price target is $12.8, which is a decrease of -8.38% from the latest price.
News
Discovery Health expanded access to mental healthcare for 22,000 members in one year, with better outcomes and lower hospital costs
BOSTON and JOHANNESBURG, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology-enabled care, today published a new case study on Discovery Health's use of SilverClou...
American Well Transcript: Morgan Stanley 24th Annual Global Healthcare Conference
The company has pivoted to focus on government and payer markets, securing major contracts with the DHA and VA while enhancing its SaaS platform and organizational discipline. Improved financial stability, renewed growth prospects, and AI-driven efficiency are central to its strategy.
Amwell gets LOI from Department of Veterans Affairs for virtual health platform
Amwell (AMWL) announced the Department of Veterans Affairs has declared its intent for the company to deploy its virtual health platform within the VA enterprise and help power the modernization…
Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced the Department of Veterans A...
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, has received Frost & Sullivan's 2026 United States Technology Innovation Leadership Reco...
Amwell® to participate in upcoming investor conferences
BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the Amwell management team will participate in the follo...
Amwell price target raised to $12 from $7.50 at Truist
Truist raised the firm’s price target on Amwell (AMWL) to $12 from $7.50 and keeps a Hold rating on the shares. The firm is updating its model after the company’s…
Amwell makes grant to new employees under inducement plan
BOSTON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announces that on August 7, Amwe...
Amwell price target raised to $13 from $6.50 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Amwell (AMWL) to $13 from $6.50 and keeps an Equal Weight rating on the shares. Revenue estimates have been stabilizing and management…
Amwell price target raised to $12 from $8 at TD Cowen
TD Cowen raised the firm’s price target on Amwell (AMWL) to $12 from $8 and keeps a Hold rating on the shares. The firm said 2Q rev/adj. EBITDA beat driven…
Amwell price target raised to $11 from $6.50 at Stifel
Stifel raised the firm’s price target on Amwell (AMWL) to $11 from $6.50 and keeps a Hold rating on the shares. Q2 revenue and EBITDA beat on stronger-than-expected subscription revenue…
American Well Earnings Call Transcript: Q2 2026
Q2 2026 saw sequential subscription revenue growth and improved margins, with a major DHA contract milestone and strong cash position. Guidance was raised for full-year revenue and EBITDA, and the company remains on track for breakeven in Q4 and double-digit growth in 2027 if pipeline contracts close.
American Well Earnings release: Q2 2026
American Well released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
American Well Quarterly report: Q2 2026
American Well has published its Q2 2026 quarterly earnings report on August 4, 2026.
Amwell reports Q2 EPS (59c), consensus (60c)
Reports Q2 revenue $52.05M, consensus $49.88M. “The DHA’s intent to make Amwell (AMWL) a prime contractor is a powerful endorsement of our platform and our people,” said Ido Schoenberg, Chairman…
Amwell® Announces Results for the Second Quarter 2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the seco...
Amwell® to report second quarter 2026 operating results
BOSTON, July 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 o...
Amwell price target raised to $16 from $9 at Wells Fargo
Wells Fargo analyst Stephen Baxter raised the firm’s price target on Amwell (AMWL) to $16 from $9 and keeps an Overweight rating on the shares. DHA’s Notice of Intent appears…
American Well Transcript: AGM 2026
Shareholders addressed director election, auditor ratification, and executive compensation. Roy Schoenberg resigned from the board, and quorum was confirmed. Final voting results will be filed on Form 8-K.
American Well Proxy statement: Proxy filing
American Well filed a proxy statement on June 9, 2026, providing details for shareholder voting and corporate governance matters.
Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale
BOSTON, May 18, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today highlighted results from an ...
American Well Transcript: 21st Annual Needham Technology, Media, & Consumer Conference
The company has transformed to focus on payer and government markets, achieving strong Q1 results with higher subscription and visit revenues, improved margins, and significant cost reductions. Major government contracts and payer renewals are set to drive growth and margin expansion, with AI adoption supporting further efficiencies.
Amwell® to Participate in Upcoming Investor Conference
BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschho...
Amwell price target raised to $6.50 from $6 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Amwell (AMWL) to $6.50 from $6 and keeps an Equal Weight rating on the shares. Revenue upside in the quarter and tighter…
Amwell price target raised to $8 from $5 at TD Cowen
TD Cowen analyst Charles Rhyee raised the firm’s price target on Amwell (AMWL) to $8 from $5 and keeps a Hold rating on the shares. The firm said the company…